{Reference Type}: Journal Article
{Title}: Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook.
{Author}: Chen T;Li S;Deng D;Zhang W;Zhang J;Shen Z;
{Journal}: J Zhejiang Univ Sci B
{Volume}: 25
{Issue}: 6
{Year}: 2024 Jun 15
{Factor}: 5.552
{DOI}: 10.1631/jzus.B2300159
{Abstract}: Interferon regulatory factor 1 (IRF-1) is a member of the IRF family. It is the first transcription factor to be identified that could bind to the interferon-stimulated response element (ISRE) on the target gene and displays crucial roles in the interferon-induced signals and pathways. IRF-1, as an important medium, has all of the advantages of full cell cycle regulation, cell death signaling transduction, and reinforcing immune surveillance, which are well documented. Current studies indicate that IRF-1 is of vital importance to the occurrence and evolution of multifarious liver diseases, including but not limited to inhibiting the replication of the hepatitis virus (A/B/C/E), alleviating the progression of liver fibrosis, and aggravating hepatic ischemia-reperfusion injury (HIRI). The tumor suppression of IRF-1 is related to the clinical characteristics of liver cancer patients, which makes it a potential indicator for predicting the prognosis and recurrence of liver cancer; additionally, the latest studies have revealed other effects of IRF-1 such as protection against alcoholic/non-alcoholic fatty liver disease (AFLD/NAFLD), cholangiocarcinoma suppression, and uncommon traits in other liver diseases that had previously received little attention. Intriguingly, several compounds and drugs have featured a protective function in specific liver disease models in which there is significant involvement of the IRF-1 signal. In this paper, we hope to propose a prospective research basis upon which to help decipher translational medicine applications of IRF-1 in liver disease treatment.<BR>干扰素调节因子1（IRF-1）是干扰素调节因子家族的重要一员，其主要功能是能够与靶基因上的干扰素刺激反应元件（ISRE）结合，进而在干扰素诱导的信号通路中发挥重要作用。IRF-1作为一种重要的转录因子，在细胞周期调控、细胞死亡信号转导、增强免疫监视等方面具有重要作用。当前研究表明，IRF-1在多种肝脏疾病的发生和发展中发挥至关重要的作用，包括抑制肝炎病的复制、缓解肝纤维化的进展和加重肝缺血再灌注损伤（HIRI）等。IRF-1还作为一种重要的肿瘤抑制因子，在临床上可作为预测肝癌预后和复发的潜在指标。此外，最新的研究还揭示了IRF-1在介导其他肝脏疾病中的潜在作用，如预防酒精性/非酒精性脂肪性肝病，抑制胆管细胞癌的生物学进展，预防细胞排斥反应等。虽然当前的研究极少涉及IRF-1的临床转化领域，但几种化合物和药物似乎可以通过激活IRF-1信号通路，在动物体特定肝脏疾病模型中发挥保护功能。在本文中，我们将综述既往文献以帮助解读IRF-1在肝脏疾病治疗中的研究进展，并提供未来转化医学应用的理论基础。.